Skip to content
10-Q

Quarterly Report

AEOLUS PHARMACEUTICALS, INC.

0001102624-16-002135

← back to feed
Filed
Feb 16, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · Feb 10, 2016 151.56M sh
Stockholders Equity Q1 2016 · Dec 31, 2015 $5.62M
Stockholders Equity Q1 2016 · Sep 30, 2015 −$845K
Current Liabilities Q1 2016 · Dec 31, 2015 $796K
Current Liabilities Q1 2016 · Sep 30, 2015 $2.62M
Total Liabilities Q1 2016 · Dec 31, 2015 $796K
Total Liabilities Q1 2016 · Sep 30, 2015 $2.62M
Current Assets Q1 2016 · Dec 31, 2015 $6.38M
Current Assets Q1 2016 · Sep 30, 2015 $1.75M
Total Assets Q1 2016 · Dec 31, 2015 $6.41M
Total Assets Q1 2016 · Sep 30, 2015 $1.78M
Shares Diluted Q1 2016 · Dec 31, 2014 135.85K sh
Operating Cash Flow Q1 2016 · Dec 31, 2014 −$1.07M
Cash And Equivalents Q1 2016 · Dec 31, 2014 $447K
Cash And Equivalents Q1 2016 · Sep 30, 2014 $1.52M
Eps Diluted Q1 2016 · Dec 31, 2014 −$0.01
Eps Basic Q1 2016 · Dec 31, 2014 −$0.01
Sga Expense Q1 2016 · Dec 31, 2014 $650K
Rd Expense Q1 2016 · Dec 31, 2014 $973K
Net Income Q1 2016 · Dec 31, 2014 −$698K
Operating Income Q1 2016 · Dec 31, 2014 −$698K